Home › Funds › PenderFund Capital Management Ltd. › ESPR
PenderFund Capital Management Ltd. position in ESPR
ESPERION THERAPEUTICS INC NE
PenderFund Capital Management Ltd. reported holding 3,884,508 shares of ESPR (ESPERION THERAPEUTICS INC NE) in its Q2 2026 13F filing — a position valued at US$12.3M, representing 2.04% of its reported portfolio and ranking #16 among its reported holdings. PenderFund Capital Management Ltd. has disclosed ESPR holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PenderFund Capital Management Ltd.'s ESPR position evolved
PenderFund Capital Management Ltd. first disclosed a stake in ESPR in Q3 2023 at 41,029,000 shares (US$29.8M). The position peaked in Q3 2024 at 40,429,000 shares, worth US$52.9M. Across 11 filings, PenderFund Capital Management Ltd. increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 3,884,508 shares valued at US$12.3M. Notable position changes include a 223% increase in Q2 2025, a 69% trim in Q3 2025, a 46% increase in Q4 2025.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 41.03M | $29.83M | New |
| Q4 2023 | 41.03M | $32.54M | Hold |
| Q1 2024 | 40.43M | $46.69M | Reduce |
| Q2 2024 | 40.43M | $51.86M | Hold |
| Q3 2024 | 40.43M | $52.94M | Hold |
| Q1 2025 | 3.00M | $196.82K | New |
| Q2 2025 | 9.68M | $9.53M | Add |
| Q3 2025 | 3.00M | $3.04M | Reduce |
| Q4 2025 | 4.39M | $16.25M | Add |
| Q1 2026 | 3.89M | $10.66M | Reduce |
| Q2 2026 | 3.88M | $12.28M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ESPR and 13F data
ESPR (ESPERION THERAPEUTICS INC NE) is a company whose sector is not yet classified in our data. 40 other funds we track also report a position in ESPR — the largest reported positions include GLAZER CAPITAL, LLC (US$70.8M), ODDO BHF ASSET MANAGEMENT SAS (US$15.8M), Beryl Capital Management LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ESPR
- GLAZER CAPITAL, LLC 22.42M sh · $70.84M · Q2 2026
- ODDO BHF ASSET MANAGEMENT SAS 5.00M sh · $15.80M · Q2 2026
- Beryl Capital Management LLC 4.43M sh · $14.00M · Q2 2026
- PSquared Asset Management AG 3.30M sh · $10.43M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 2.96M sh · $9.34M · Q2 2026
- TIG Advisors, LLC 2.59M sh · $8.18M · Q2 2026
- GABELLI & Co INVESTMENT ADVISERS, INC. 2.32M sh · $7.32M · Q2 2026
- GARDNER LEWIS ASSET MANAGEMENT L P 1.37M sh · $4.31M · Q2 2026
More on PenderFund Capital Management Ltd.
FAQ
How long has PenderFund Capital Management Ltd. held ESPR?
PenderFund Capital Management Ltd. has disclosed ESPR holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is PenderFund Capital Management Ltd.'s current position in ESPR?
As of Q2 2026, PenderFund Capital Management Ltd. holds 3.88M shares of ESPR (ESPERION THERAPEUTICS INC NE), valued at $12.28M, representing 2.04% of its reported portfolio and ranking #16.
Has PenderFund Capital Management Ltd. been buying or selling ESPR?
In the latest 13F filing (Q2 2026), PenderFund Capital Management Ltd. held unchanged its position in ESPR. The position peaked in Q3 2024 at 40.43M shares.
Which other funds hold ESPR?
Other major institutional holders of ESPR include GLAZER CAPITAL, LLC, ODDO BHF ASSET MANAGEMENT SAS, Beryl Capital Management LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.